<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00508976</url>
  </required_header>
  <id_info>
    <org_study_id>PHH#07-005</org_study_id>
    <nct_id>NCT00508976</nct_id>
  </id_info>
  <brief_title>Clinical Proposal for the Comparison of Intraperitoneal Anesthetic to Injected Local Anesthetic</brief_title>
  <official_title>Evaluation of Aerosolized Bupivacaine Versus Pre-incision Lidocaine Versus Instilled Liquid Bupivacaine Versus Post-operative Bupivacaine Injection for Optimization of Post-operative Pain Control in Laparoscopic Bariatric Surgical Patients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Pinnacle Health System</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Pinnacle Health System</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine if pre-incisional lidocaine injection, instilled
      liquid bupivacaine, intra-abdominal aerosolized bupivacaine, or post-operative bupivacaine
      injection is superior in post-operative pain control in laparoscopic bariatric surgical
      patients.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The research objective is to compare our standard post-operative port site injection of 0.5%
      bupivacaine against pre-incisional port site injection of 1% lidocaine against the
      instillation of streamed bupivacaine 0.5% against the instillation of aerosolized 0.5%
      bupivacaine as it relates to post-operative analgesia usage and pain scale scores. The null
      hypothesis will be that there is no difference between the four arms of the study in regards
      to pain score and analgesia usage.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>June 2007</start_date>
  <completion_date type="Actual">April 2008</completion_date>
  <primary_completion_date type="Actual">April 2008</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Factorial Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Participant, Care Provider, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Measure of reduction in post-operative pain and narcotics usage.</measure>
    <time_frame>First 3 days post-operatively.</time_frame>
  </primary_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Actual">100</enrollment>
  <condition>Pain, Postoperative</condition>
  <condition>Morbid Obesity</condition>
  <arm_group>
    <arm_group_label>3</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>2</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>4</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>1</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Injected bupivacaine post-operatively</intervention_name>
    <description>Patients will receive 30 ml of 0.9% normal saline divided equally and injected prior to port site incision, then 10ml of 0.9% normal saline streamed via port directed at operative field, then 10ml of 0.9% normal saline aerosolized into the coelomic cavity prior to deflation, and our current standard of care, which is 30ml of 0.5% bupivacaine, divided equally between the five port-sites, injected at the end of the operation.</description>
    <arm_group_label>1</arm_group_label>
    <other_name>bupivacaine</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Streamed bupivacaine versus streamed normal saline</intervention_name>
    <description>Patients will receive 30ml of 0.9% normal saline divided equally and injected prior to port site incisions, then 10ml of 0.5% bupivacaine streamed via port directed at operative field, then 10ml of 0.9% normal saline aerosolized into the coelomic cavity prior to deflation and our current standard of care, which is 30ml of 0.5% bupivacaine, divided equally between the five port-sites, injected at the end of the operation.</description>
    <arm_group_label>3</arm_group_label>
    <other_name>bupivacaine</other_name>
    <other_name>marcaine</other_name>
    <other_name>normal saline</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Aerosolized bupivacaine versus aerosolized saline</intervention_name>
    <description>Patients will receive 30 ml of 0.9% normal saline divided equally and injected prior to port site incision, then 10ml of 0.9% normal saline streamed via port directed at operative field, then 10ml of 0.5% bupivacaine aerosolized into coelomic cavity prior to deflation and our current standard of care, which is 30ml of 0.5% bupivacaine, divided equally between the five port-sites, injected at the end of the operation.</description>
    <arm_group_label>4</arm_group_label>
    <other_name>bupivacaine</other_name>
    <other_name>marcaine</other_name>
    <other_name>normal saline</other_name>
    <other_name>aerosolized</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Injected lidocaine pre-incision vs saline pre-incision</intervention_name>
    <description>Patients will receive 30ml of 1% lidocaine divided equally and injected prior to port site incisions, then 10ml of 0.9% normal saline streamed via port directed at operative field, then 10ml of 0.9% normal saline aerosolized into the coelomic cavity prior to deflation and our current standard of care, which is 30ml of 0.5% bupivacaine, divided equally between the five port-sites, injected at the end of the operation.</description>
    <arm_group_label>2</arm_group_label>
    <other_name>lidocaine</other_name>
    <other_name>normal saline</other_name>
    <other_name>pre-emptive</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Male and female patients between 18 and 65 years of age.

          2. Patients undergoing elective bariatric surgery.

        Exclusion Criteria:

          1. Patients allergic to bupivacaine or any other local anesthetics (amides &amp; esters).

          2. Patients who have used opiates or opiods within 15 days prior to surgery.

          3. Patients converted to open gastric bypass.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Troy A Moritz, DO</last_name>
    <role>Principal Investigator</role>
    <affiliation>Pinnacle Health; Community General Osteopathic Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Pinnacle Health; Community General Osteopathic Hospital</name>
      <address>
        <city>Harrisburg</city>
        <state>Pennsylvania</state>
        <zip>17109</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Aida S, Baba H, Yamakura T, Taga K, Fukuda S, Shimoji K. The effectiveness of preemptive analgesia varies according to the type of surgery: a randomized, double-blind study. Anesth Analg. 1999 Sep;89(3):711-6.</citation>
    <PMID>10475311</PMID>
  </reference>
  <reference>
    <citation>Alkhamesi NA, Peck DH, Lomax D, Darzi AW. Intraperitoneal aerosolization of bupivacaine reduces postoperative pain in laparoscopic surgery: a randomized prospective controlled double-blinded clinical trial. Surg Endosc. 2007 Apr;21(4):602-6. Epub 2006 Dec 16.</citation>
    <PMID>17180268</PMID>
  </reference>
  <reference>
    <citation>Barczy≈Ñski M, Konturek A, Herman RM. Superiority of preemptive analgesia with intraperitoneal instillation of bupivacaine before rather than after the creation of pneumoperitoneum for laparoscopic cholecystectomy: a randomized, double-blind, placebo-controlled study. Surg Endosc. 2006 Jul;20(7):1088-93. Epub 2006 May 13.</citation>
    <PMID>16703434</PMID>
  </reference>
  <reference>
    <citation>Chou YJ, Ou YC, Lan KC, Jawan B, Chang SY, Kung FT. Preemptive analgesia installation during gynecologic laparoscopy: a randomized trial. J Minim Invasive Gynecol. 2005 Jul-Aug;12(4):330-5.</citation>
    <PMID>16036193</PMID>
  </reference>
  <reference>
    <citation>Einarsson JI, Sun J, Orav J, Young AE. Local analgesia in laparoscopy: a randomized trial. Obstet Gynecol. 2004 Dec;104(6):1335-9.</citation>
    <PMID>15572499</PMID>
  </reference>
  <reference>
    <citation>Fletcher D, Kayser V, Guilbaud G. Influence of timing of administration on the analgesic effect of bupivacaine infiltration in carrageenin-injected rats. Anesthesiology. 1996 May;84(5):1129-37.</citation>
    <PMID>8624007</PMID>
  </reference>
  <reference>
    <citation>Huang SJ, Wang JJ, Ho ST, Liu HS, Liaw WJ, Li MJ, Liu YH. The preemptive effect of pre-incisional bupivacaine infiltration on postoperative analgesia following lower abdominal surgery under epidural anesthesia. Acta Anaesthesiol Sin. 1997 Jun;35(2):97-102. Erratum in: Acta Anaesthesiol Sin 1997 Sep;35(3):191.</citation>
    <PMID>9293650</PMID>
  </reference>
  <reference>
    <citation>Ke RW, Portera SG, Bagous W, Lincoln SR. A randomized, double-blinded trial of preemptive analgesia in laparoscopy. Obstet Gynecol. 1998 Dec;92(6):972-5.</citation>
    <PMID>9840560</PMID>
  </reference>
  <reference>
    <citation>Kundu S, Achar S. Principles of office anesthesia: part II. Topical anesthesia. Am Fam Physician. 2002 Jul 1;66(1):99-102. Review.</citation>
    <PMID>12126037</PMID>
  </reference>
  <reference>
    <citation>Lam KW, Pun TC, Ng EH, Wong KS. Efficacy of preemptive analgesia for wound pain after laparoscopic operations in infertile women: a randomised, double-blind and placebo control study. BJOG. 2004 Apr;111(4):340-4.</citation>
    <PMID>15008770</PMID>
  </reference>
  <reference>
    <citation>Lohsiriwat V, Lert-akyamanee N, Rushatamukayanunt W. Efficacy of pre-incisional bupivacaine infiltration on postoperative pain relief after appendectomy: prospective double-blind randomized trial. World J Surg. 2004 Oct;28(10):947-50. Epub 2004 Sep 29.</citation>
    <PMID>15573244</PMID>
  </reference>
  <reference>
    <citation>Jiranantarat V, Rushatamukayanunt W, Lert-akyamanee N, Sirijearanai R, Piromrat I, Suwannanonda P, Muangkasem J. Analgesic effect of intraperitoneal instillation of bupivacaine for postoperative laparoscopic cholecystectomy. J Med Assoc Thai. 2002 Sep;85 Suppl 3:S897-903.</citation>
    <PMID>12452227</PMID>
  </reference>
  <reference>
    <citation>Maestroni U, Sortini D, Devito C, Pour Morad Kohan Brunaldi F, Anania G, Pavanelli L, Pasqualucci A, Donini A. A new method of preemptive analgesia in laparoscopic cholecystectomy. Surg Endosc. 2002 Sep;16(9):1336-40. Epub 2002 May 7.</citation>
    <PMID>11988800</PMID>
  </reference>
  <reference>
    <citation>Mixter CG 3rd, Hackett TR. Preemptive analgesia in the laparoscopic patient. Surg Endosc. 1997 Apr;11(4):351-3.</citation>
    <PMID>9094275</PMID>
  </reference>
  <reference>
    <citation>M√∏iniche S, Kehlet H, Dahl JB. A qualitative and quantitative systematic review of preemptive analgesia for postoperative pain relief: the role of timing of analgesia. Anesthesiology. 2002 Mar;96(3):725-41. Review.</citation>
    <PMID>11873051</PMID>
  </reference>
  <reference>
    <citation>Mouton WG, Bessell JR, Otten KT, Maddern GJ. Pain after laparoscopy. Surg Endosc. 1999 May;13(5):445-8. Review.</citation>
    <PMID>10227938</PMID>
  </reference>
  <reference>
    <citation>Mouton WG, Bessell JR, Pfitzner J, Dymock RB, Brealey J, Maddern GJ. A randomized controlled trial to determine the effects of humidified carbon dioxide insufflation during thoracoscopy. Surg Endosc. 1999 Apr;13(4):382-5.</citation>
    <PMID>10094752</PMID>
  </reference>
  <reference>
    <citation>Mouton WG, Bessell JR, Millard SH, Baxter PS, Maddern GJ. A randomized controlled trial assessing the benefit of humidified insufflation gas during laparoscopic surgery. Surg Endosc. 1999 Feb;13(2):106-8.</citation>
    <PMID>9918607</PMID>
  </reference>
  <reference>
    <citation>Ong CK, Lirk P, Seymour RA, Jenkins BJ. The efficacy of preemptive analgesia for acute postoperative pain management: a meta-analysis. Anesth Analg. 2005 Mar;100(3):757-73, table of contents.</citation>
    <PMID>15728066</PMID>
  </reference>
  <verification_date>May 2012</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 26, 2007</study_first_submitted>
  <study_first_submitted_qc>July 26, 2007</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 30, 2007</study_first_posted>
  <last_update_submitted>May 9, 2012</last_update_submitted>
  <last_update_submitted_qc>May 9, 2012</last_update_submitted_qc>
  <last_update_posted type="Estimate">May 10, 2012</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Pinnacle Health System</investigator_affiliation>
    <investigator_full_name>Troy Moritz, D.O.</investigator_full_name>
    <investigator_title>Troy Moritz DO</investigator_title>
  </responsible_party>
  <keyword>bupivacaine</keyword>
  <keyword>marcaine</keyword>
  <keyword>lidocaine</keyword>
  <keyword>normal saline</keyword>
  <keyword>narcotics</keyword>
  <keyword>analog pain scale</keyword>
  <keyword>postoperative pain</keyword>
  <keyword>preemptive</keyword>
  <keyword>aerosolization</keyword>
  <keyword>streamed</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pain, Postoperative</mesh_term>
    <mesh_term>Obesity, Morbid</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Bupivacaine</mesh_term>
    <mesh_term>Lidocaine</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

